Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 12368195)

1.

CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.

Kristiansen G, Denkert C, Schlüns K, Dahl E, Pilarsky C, Hauptmann S.

Am J Pathol. 2002 Oct;161(4):1215-21.

2.

Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors.

Choi YL, Kim SH, Shin YK, Hong YC, Lee SJ, Kang SY, Ahn G.

Gynecol Oncol. 2005 May;97(2):379-86.

PMID:
15863133
3.

CD24 expression is a new prognostic marker in breast cancer.

Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M.

Clin Cancer Res. 2003 Oct 15;9(13):4906-13.

4.

Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.

Denkert C, Weichert W, Pest S, Koch I, Licht D, Köbel M, Reles A, Sehouli J, Dietel M, Hauptmann S.

Cancer Res. 2004 Jan 1;64(1):189-95.

5.

CD24 expression is a poor prognostic marker in endometrial carcinoma.

Karahan N, Güney M, Oral B, Kapucuoglu N, Mungan T.

Eur J Gynaecol Oncol. 2006;27(5):500-4.

PMID:
17139987
7.

c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.

Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S.

Croat Med J. 2003 Aug;44(4):429-34.

8.

Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.

Osada R, Horiuchi A, Kikuchi N, Yoshida J, Hayashi A, Ota M, Katsuyama Y, Melillo G, Konishi I.

Hum Pathol. 2007 Sep;38(9):1310-20. Epub 2007 Jun 6. Erratum in: Hum Pathol. 2008 Jan;39(1):147. Mellilo, Giovanni [corrected to Melillo, Giovanni].

PMID:
17555795
9.

The role of CD24 in various human epithelial neoplasias.

Lim SC, Oh SH.

Pathol Res Pract. 2005;201(7):479-86.

PMID:
16164042
10.

Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.

Zuna RE, Behrens A.

J Natl Cancer Inst. 1996 Jul 17;88(14):980-7.

11.

CD24, COX-2, and p53 in epithelial ovarian cancer and its clinical significance.

Zhu J, Zhang G, Lu H.

Front Biosci (Elite Ed). 2012 Jun 1;4:2745-51.

PMID:
22652675
12.

Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.

Yang GF, Xie D, Liu JH, Luo JH, Li LJ, Hua WF, Wu HM, Kung HF, Zeng YX, Guan XY.

Gynecol Oncol. 2009 Feb;112(2):314-8. doi: 10.1016/j.ygyno.2008.10.024. Epub 2008 Dec 2.

PMID:
19054548
13.

Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.

Denkert C, Schmitt WD, Berger S, Reles A, Pest S, Siegert A, Lichtenegger W, Dietel M, Hauptmann S.

Int J Cancer. 2002 Dec 10;102(5):507-13.

PMID:
12432554
14.

Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival.

Weichert W, Denkert C, Burkhardt M, Gansukh T, Bellach J, Altevogt P, Dietel M, Kristiansen G.

Clin Cancer Res. 2005 Sep 15;11(18):6574-81.

15.
16.

Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.

Tafe LJ, Garg K, Chew I, Tornos C, Soslow RA.

Mod Pathol. 2010 Jun;23(6):781-9. doi: 10.1038/modpathol.2010.41. Epub 2010 Mar 19.

17.

Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patients.

Surowiak P, Materna V, Kłak K, Spaczyński M, Dietel M, Kristiansen G, Lage H, Zabel M.

Pol J Pathol. 2005;56(2):69-74.

PMID:
16092668
18.
19.

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients.

Kristiansen G, Schlüns K, Yongwei Y, Denkert C, Dietel M, Petersen I.

Br J Cancer. 2003 Jan 27;88(2):231-6.

20.

[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].

Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.

Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32. Chinese.

PMID:
17631760
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk